Connection

Simon Cauchemez to Risk Assessment

Back to Details
This is a "connection" page, showing publications Simon Cauchemez has written about Risk Assessment.
Simon Cauchemez
Connection Strength
0.177
Risk Assessment
  1. Managing COVID-19 importation risks in a heterogeneous world. Lancet Public Health. 2021 09; 6(9):e626-e627.
    View in: PubMed
    Score: 0.041
  2. Benefits and risks associated with different uses of the COVID-19 vaccine Vaxzevria: a modelling study, France, May to September 2021. Euro Surveill. 2021 07; 26(26).
    View in: PubMed
    Score: 0.041
  3. Risk for Transportation of Coronavirus Disease from Wuhan to Other Cities in China. Emerg Infect Dis. 2020 05; 26(5):1049-1052.
    View in: PubMed
    Score: 0.038
  4. Middle East respiratory syndrome coronavirus: quantification of the extent of the epidemic, surveillance biases, and transmissibility. Lancet Infect Dis. 2014 Jan; 14(1):50-56.
    View in: PubMed
    Score: 0.024
  5. Transmission scenarios for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and how to tell them apart. Euro Surveill. 2013 Jun 13; 18(24).
    View in: PubMed
    Score: 0.023
  6. Do not neglect SARS-CoV-2 hospitalization and fatality risks in the middle-aged adult population. Infect Dis Now. 2021 Jun; 51(4):380-382.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.